| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| TRAW | TRAW | Shares | USD | XNCM |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| TRAW | TRAW | Shares | USD | XNCM |
Traws Pharma, Inc. is a clinical stage biopharmaceutical company focused on developing novel antiviral therapies for respiratory viral diseases. The company is advancing two investigational oral small molecule antivirals: Ratutrelvir, aimed at treating COVID-19 and Long COVID, and Tivoxavir marboxil, designed for bird flu and seasonal influenza. Traws Pharma targets difficult-to-treat virus strains and employs accelerated clinical trial strategies to ensure safety and effective dosing for vulnerable patient populations.
No recent RNS announcements for TRAW across TRAW.
No recent RNS announcements for TRAW across TRAW.